Ischemic Stroke
Conditions
Interventions
Experimental group:acupuncture
Control group:sham acupuncture
Sponsors
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients 3-14 days after ischemic stroke; 2. Aged 18-75 years; 3. Clear consciousness, stable vital signs, no obvious mental retardation, Mini-Mental State Examination (MMSE) score in the normal range (normal threshold: illiterate > 17 points, primary school > 20 points, junior high school and above > 24 points), can cooperate with acupuncture, rehabilitation training and related basic treatment; 4. Modified Rankin Score (mRS) score before stroke <= 1 point; National Institute of Health Stroke Scale (NIHSS) score between 5-15 after onset; 5. Those who understand the trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Transient ischemic attack, reversible neurological deficit; 2. Those whose neurological deficits are confirmed by examinations to be caused by diseases such as brain tumor, brain trauma, cerebral hemorrhage, and brain parasites, and whose life expectancy is less than 1 year for reasons other than stroke; 3. Patients with contraindications to acupuncture, or patients with stroke complicated by severe circulatory system, respiratory system, digestive system, urinary system, endocrine system and hematopoietic system and other primary diseases that cannot be controlled by conventional medication; patients with combined tumors, patients with severe infection, water, electrolyte and acid-base balance disorders; or other patients with abnormal examinations judged by the investigator to be unsuitable to participate in this trial; 4. Those with severe aphasia, sleep apnea, deafness, severe cognitive impairment and even unable to communicate normally; or those who are participating in other clinical research trials; 5. Patients with severe depression, anxiety, or patients with other mental illnesses; 6. Patients who are pregnant or planning to become pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Rankin Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| National Institutes of Health Stroke Scale;Modified Barhtel Index Rating Scale;Modified Ashworth Scale;Simplified Fugl-Meyer Motor Function Score;MRI; | — |
Countries
China
Contacts
Public ContactZhuang Lixing
Outcome results
None listed